nimacimab
nimacimab: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Skye Bioscience, Inc. (SKYE) | Phase 2 |
Clinical Trials (1)
A Phase 2 Study of QW Nimacimab Injection, Compared to Placebo Injection and QW Weekly Nimacimab Injection Co-administered With Semaglutide in Participants Who Are Overweight or Obese
Frequently asked questions
Who is developing nimacimab?
nimacimab is being developed by Skye Bioscience, Inc..
How many clinical trials involve nimacimab?
BioSniper tracks 1 clinical trial involving nimacimab.
Get deeper analysis on nimacimab
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis